Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

ABSTRACT: Background: Hypoalbuminemia is a hallmark of critical illness, reflecting both systemic inflammation and impaired homeostasis. This systematic review and meta-analysis examine the prognostic ...

A study shows that people with higher levels of the protein albumin in their urine are at increased risk of developing dementia. The study, led by researchers at Karolinska Institutet, is published in ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Please provide your email address to receive an email when new articles are posted on . Patients had a mean change in albumin levels of 0.33 g/dL after 6 months of nutrition therapy. In addition, 82% ...

Abstract: In this work, we establish a bovine serum albumin (BSA) concentration measurement model based on a cascaded Vernier sensing structure combined with ensemble learning algorithm, which ...

Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.